Last reviewed · How we verify
Yinzhihuang Oral Liquid
Yinzhihuang Oral Liquid is a Small molecule drug developed by Southern Medical University, China. It is currently FDA-approved. Also known as: Huarun Yinzhihuang Oral solution.
At a glance
| Generic name | Yinzhihuang Oral Liquid |
|---|---|
| Also known as | Huarun Yinzhihuang Oral solution |
| Sponsor | Southern Medical University, China |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Yinzhihuang Oral Liquid CI brief — competitive landscape report
- Yinzhihuang Oral Liquid updates RSS · CI watch RSS
- Southern Medical University, China portfolio CI
Frequently asked questions about Yinzhihuang Oral Liquid
What is Yinzhihuang Oral Liquid?
Yinzhihuang Oral Liquid is a Small molecule drug developed by Southern Medical University, China.
Who makes Yinzhihuang Oral Liquid?
Yinzhihuang Oral Liquid is developed and marketed by Southern Medical University, China (see full Southern Medical University, China pipeline at /company/southern-medical-university-china).
Is Yinzhihuang Oral Liquid also known as anything else?
Yinzhihuang Oral Liquid is also known as Huarun Yinzhihuang Oral solution.
What development phase is Yinzhihuang Oral Liquid in?
Yinzhihuang Oral Liquid is FDA-approved (marketed).
Related
- Manufacturer: Southern Medical University, China — full pipeline
- Also known as: Huarun Yinzhihuang Oral solution
- Compare: Yinzhihuang Oral Liquid vs similar drugs
- Pricing: Yinzhihuang Oral Liquid cost, discount & access